For instance, recognition by pathologists of a gastrointestinal tract tumour that was neither of smooth muscle nor of nerve sheath origin and that is now recognised as “gastrointestinal stromal tumour” and is now treated with c-kit inhibitors has changed the clinical management and outcome of this disease [59]. This evidence concerns the gene KIT and gastrointestinal stromal tumor.